GH
Guardant Health Inc
NASDAQ: GH · HEALTHCARE · DIAGNOSTICS & RESEARCH
$144.07
+0.31% today
Updated 2026-07-29
Market cap
$20.67B
P/E ratio
—
P/S ratio
19.13x
EPS (TTM)
$-3.40
Dividend yield
—
52W range
$40 – $174
Volume
2.8M
Guardant Health Inc (GH) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$144.07
12-Month target
—
2030 Target
—
Intrinsic (DCF)
—
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 | 2027 (E) | 2028 (E) | 2029 (E) | 2030 (E) |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.4B | $0.4B | $0.6B | $0.7B | $1.0B | $1.2B | $1.4B | $1.7B | $2.0B |
| EPS | — | — | — | — | — | — | — | — | — |
CAGR applied: 20.00% (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -40.10%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.